|
“Mantle Cell Lymphoma (MCL) is an aggressive (fast-growing) type
of B-cell non-Hodgkin lymphoma that usually occurs in middle-aged or older
adults. It is marked by small- to medium-size cancer cells that may be in the
lymph nodes, spleen, bone marrow, blood, and gastrointestinal system.”[1]
If you or a family member or a friend has been diagnosed with Mantle
Cell Lymphoma (MCL), you may be eligible to participate in this clinical trial.
Please click on the link below to take a brief screening questionnaire to see if
you may be eligible.
[1] Source: Dictionary of Cancer Terms/Mantle Cell
Lymphoma http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=445048. August 5,
2008
To view all Novartis clinical trials recruiting in the U.S., visit
NovartisClinicalTrials.com
|
For U.S. residents only.
Non-U.S. residents
